Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Proctor

Showing results (201-210 of 293) with videos related to

Pageof 30
Sort By:
Regulatory Toxicology and Pharmacology : RTP|April 24, 2018
An Adverse Outcome Pathway (AOP) for forestomach tumors induced by non-genotoxic initiating eventsDeborah M Proctor, Mina Suh, Grace Chappell, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 1, 1987
Endemic institutional strongyloidiasis in British ColumbiaE M Proctor, H A Muth, D L Proudfoot, et al.
Regulatory Toxicology and Pharmacology : RTP|June 19, 2012
Assessment of genotoxic potential of Cr(VI) in the mouse duodenum: an in silico comparison with mutagenic and nonmutagenic carcinogens across tissuesChad M Thompson, J Gregory Hixon, Deborah M Proctor, et al.
Environmental and Molecular Mutagenesis|May 14, 2015
A robust method for assessing chemically induced mutagenic effects in the oral cavity of transgenic Big Blue® ratsRobert R Young, Chad M Thompson, Harshini R Dinesdurage, et al.
Regulatory Toxicology and Pharmacology : RTP|July 12, 2020
Exposure to environmentally-relevant concentrations of hexavalent chromium does not induce ovarian toxicity in miceChad M Thompson, Douglas A Donahue, Cheryl Hobbs, et al.
Journal of Toxicology and Environmental Health. Part A|May 25, 2002
Is hexavalent chromium carcinogenic via ingestion? A weight-of-evidence reviewDeborah M Proctor, Joanne M Otani, Brent L Finley, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 17, 2007
Grb2 is required for atherosclerotic lesion formationBrandon M Proctor, Jie Ren, Zhouji Chen, et al.
Drug Testing and Analysis|January 21, 2023
Automated identification of unknown doping agents in confiscation samples by flow-injection mass spectrometry and mass spectral library searchesFuyu Guan, Savannah Fay, Matthew A Adreance, et al.
Plos One|August 21, 2012
Assessment of Cr(VI)-induced cytotoxicity and genotoxicity using high content analysisChad M Thompson, Yuriy Fedorov, Daniel D Brown, et al.
Journal of Occupational and Environmental Hygiene|May 28, 2025
Lung cancer risk assessment associated with exposure to hexavalent chromium: Results of pooled analysis of three cohortsBruce C Allen, Melissa J Vincent, Loren Lipworth, et al.
Pageof 30

Showing results (201-210 of 293) with videos related to

Sort By:
Pageof 30
Regulatory Toxicology and Pharmacology : RTP|April 24, 2018
An Adverse Outcome Pathway (AOP) for forestomach tumors induced by non-genotoxic initiating eventsDeborah M Proctor, Mina Suh, Grace Chappell, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 1, 1987
Endemic institutional strongyloidiasis in British ColumbiaE M Proctor, H A Muth, D L Proudfoot, et al.
Regulatory Toxicology and Pharmacology : RTP|June 19, 2012
Assessment of genotoxic potential of Cr(VI) in the mouse duodenum: an in silico comparison with mutagenic and nonmutagenic carcinogens across tissuesChad M Thompson, J Gregory Hixon, Deborah M Proctor, et al.
Environmental and Molecular Mutagenesis|May 14, 2015
A robust method for assessing chemically induced mutagenic effects in the oral cavity of transgenic Big Blue® ratsRobert R Young, Chad M Thompson, Harshini R Dinesdurage, et al.
Regulatory Toxicology and Pharmacology : RTP|July 12, 2020
Exposure to environmentally-relevant concentrations of hexavalent chromium does not induce ovarian toxicity in miceChad M Thompson, Douglas A Donahue, Cheryl Hobbs, et al.
Journal of Toxicology and Environmental Health. Part A|May 25, 2002
Is hexavalent chromium carcinogenic via ingestion? A weight-of-evidence reviewDeborah M Proctor, Joanne M Otani, Brent L Finley, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 17, 2007
Grb2 is required for atherosclerotic lesion formationBrandon M Proctor, Jie Ren, Zhouji Chen, et al.
Drug Testing and Analysis|January 21, 2023
Automated identification of unknown doping agents in confiscation samples by flow-injection mass spectrometry and mass spectral library searchesFuyu Guan, Savannah Fay, Matthew A Adreance, et al.
Plos One|August 21, 2012
Assessment of Cr(VI)-induced cytotoxicity and genotoxicity using high content analysisChad M Thompson, Yuriy Fedorov, Daniel D Brown, et al.
Journal of Occupational and Environmental Hygiene|May 28, 2025
Lung cancer risk assessment associated with exposure to hexavalent chromium: Results of pooled analysis of three cohortsBruce C Allen, Melissa J Vincent, Loren Lipworth, et al.
Pageof 30